174 related articles for article (PubMed ID: 31448820)
1. A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Russell MC; Cardona K; Sullivan PS; Maithel SK
J Surg Oncol; 2019 Nov; 120(6):932-939. PubMed ID: 31448820
[TBL] [Abstract][Full Text] [Related]
2. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Lymph Node Metastasis of Rectal Neuroendocrine Tumor and Its Prognostic Impact: A Single-Center Retrospective Analysis of 195 Cases with Radical Resection.
Hiyoshi Y; Daitoku N; Mukai T; Nagasaki T; Yamaguchi T; Akiyoshi T; Yasue C; Chino A; Saito S; Takamatsu M; Fukunaga Y
Ann Surg Oncol; 2023 Jul; 30(7):3944-3953. PubMed ID: 36935432
[TBL] [Abstract][Full Text] [Related]
4. Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours.
Kim BC; Kim YE; Chang HJ; Lee SH; Youk EG; Lee DS; Lee JB; Lee EJ; Kim MJ; Sohn DK; Oh JH
Colorectal Dis; 2016 Jul; 18(7):O243-51. PubMed ID: 27166857
[TBL] [Abstract][Full Text] [Related]
5. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
[TBL] [Abstract][Full Text] [Related]
6. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
[TBL] [Abstract][Full Text] [Related]
7. Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter data.
Wei G; Feng X; Wang W; Zhang Y; Zeng Y; Chen M; Chen Y; Chen J; Zhou Z; Li Y
Future Oncol; 2018 Aug; 14(18):1817-1823. PubMed ID: 30019936
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
9. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
[TBL] [Abstract][Full Text] [Related]
10. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
11. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
[TBL] [Abstract][Full Text] [Related]
12. Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
Kudou M; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Shoda K; Kosuga T; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2019 Jan; 39(1):505-510. PubMed ID: 30591502
[TBL] [Abstract][Full Text] [Related]
13. New lymph node staging for rectal neuroendocrine tumors.
Fields AC; McCarty JC; Ma-Pak L; Lu P; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N
J Surg Oncol; 2019 Jan; 119(1):156-162. PubMed ID: 30481376
[TBL] [Abstract][Full Text] [Related]
14. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.
Blakely AM; Raoof M; Ituarte PHG; Fong Y; Singh G; Lee B
Ann Surg Oncol; 2019 Nov; 26(12):4008-4015. PubMed ID: 31359272
[TBL] [Abstract][Full Text] [Related]
16. Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).
Rault-Petit B; Do Cao C; Guyétant S; Guimbaud R; Rohmer V; Julié C; Baudin E; Goichot B; Coriat R; Tabarin A; Ramos J; Goudet P; Hervieu V; Scoazec JY; Walter T
Ann Surg; 2019 Jul; 270(1):165-171. PubMed ID: 29557879
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors.
Fujii Y; Tzeng CW; Chiang YJ; Halperin DM; Dasari A; Kim MP; Katz MHG; Lee JE; Ikoma N
J Surg Res; 2021 Dec; 268():419-431. PubMed ID: 34416414
[TBL] [Abstract][Full Text] [Related]
18. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
19. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]